CORD-19:954e351a7d8b5d4c275b9af0b053ce983d334547 / 166837-167163 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T105","span":{"begin":0,"end":326},"obj":"Sentence"}],"text":"404 Because of its rheologic properties (i.e., the ability to increase erythrocyte deformability and microvascular blood flow), pentoxifylline has been suggested for use in endotoxemic patients showing evidence of laminitis; however, no effect on blood flow to the hoof was demonstrated after administration to healthy horses."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T58738","span":{"begin":0,"end":326},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"404 Because of its rheologic properties (i.e., the ability to increase erythrocyte deformability and microvascular blood flow), pentoxifylline has been suggested for use in endotoxemic patients showing evidence of laminitis; however, no effect on blood flow to the hoof was demonstrated after administration to healthy horses."}

{"project":"Epistemic_Statements","denotations":[{"id":"T458","span":{"begin":0,"end":326},"obj":"Epistemic_statement"}],"text":"404 Because of its rheologic properties (i.e., the ability to increase erythrocyte deformability and microvascular blood flow), pentoxifylline has been suggested for use in endotoxemic patients showing evidence of laminitis; however, no effect on blood flow to the hoof was demonstrated after administration to healthy horses."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T530","span":{"begin":270,"end":273},"obj":"Disease"}],"attributes":[{"id":"A530","pred":"mondo_id","subj":"T530","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"404 Because of its rheologic properties (i.e., the ability to increase erythrocyte deformability and microvascular blood flow), pentoxifylline has been suggested for use in endotoxemic patients showing evidence of laminitis; however, no effect on blood flow to the hoof was demonstrated after administration to healthy horses."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T597","span":{"begin":115,"end":120},"obj":"Body_part"},{"id":"T598","span":{"begin":247,"end":252},"obj":"Body_part"},{"id":"T599","span":{"begin":265,"end":269},"obj":"Body_part"}],"attributes":[{"id":"A597","pred":"uberon_id","subj":"T597","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A598","pred":"uberon_id","subj":"T598","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A599","pred":"uberon_id","subj":"T599","obj":"http://purl.obolibrary.org/obo/UBERON_0008963"}],"text":"404 Because of its rheologic properties (i.e., the ability to increase erythrocyte deformability and microvascular blood flow), pentoxifylline has been suggested for use in endotoxemic patients showing evidence of laminitis; however, no effect on blood flow to the hoof was demonstrated after administration to healthy horses."}